T1	Citation 593 597	[20]
T2	Context 432 598	Basal-like and Claudin-low carcinomas are mostly triple negative breast cancers (ER-PR-Her2-) associated with high resistance to chemotherapy and poor prognosis [20].
T3	ACCURATE 50014 50134	Acquisition of EMT and/or stem cell-like biological processes has been associated with therapeutic resistance [7,43,44].
A1	Level T3 Sentence
T4	ACCURATE 2329 2632	Clinically, the majority of claudin-low tumors are poor prognosis estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and epidermal growth factor receptor 2 (HER2)-negative (triple negative) invasive ductal carcinomas with a high frequency of metaplastic and medullary differentiation.
A2	Level T4 Sentence
T6	ACCURATE 34760 34947	These findings suggest that claudin-low tumors show some chemotherapy sensitivity but overall have a poor prognosis and may not be managed effectively with existing chemotherapy regimens.
A4	Level T6 Sentence
